Bid Banana
PricingBid helpAPILog inStart free trial
Log inStart free trial

Learn more

  • Louisiana guideLouisiana Bids and Bidding Guide
  • Healthcare RFPsHealthcare and Medical Services Bids and Bidding Guide
  • How to answer an RFPChoosing and Responding to Government Bids
More healthcare and medical services bids →Must-win bid? Bring in The Bid Lab →
Bid Banana
SearchPricingBid helpBrowse bidsAPISupportFAQPrivacy PolicyTerms of UseAI Use Policy

This website and its content is copyright of The Bid Lab © 2026. The Bid Lab is a trademark of Bid Lab, LLC. All rights reserved.

  1. Bid Banana
  2. ›Closed bids
  3. ›Louisiana
  4. ›Healthcare and Medical Services
  5. ›Genetic Diseases/Hydrox. - LDH

Louisiana Department of Health (LDH)·Louisiana

Genetic Diseases/Hydrox. - LDH

Closes 3/4/2026$100k – $500kRequest for Proposal
Bid source

This opportunity has closed.

Bid Banana tracks 1.6M+ bids and awards across all 50 states. Save a search and we'll email your new matches, daily or weekly — so the next one reaches you with time to bid.

Get alerted next time

Description

The Louisiana Department of Health (LDH) is seeking a vendor to provide Hydroxocobalamin Injections. The successful vendor will be required to mix the powdered Hydroxocobalamin into an injectable solution according to a specific formula and follow strict guidelines for sterility and testing. The vendor must be accredited by The Joint Commission, the Accreditation Commission for Health Care (ACHC), and have Pharmacy Compounding Accreditation Board (PCAB) Accreditation. Deliveries must be made within 2 calendar days of order receipt, and all delivery charges must be included in the bid price. Key requirements include: • Accreditation by The Joint Commission and ACHC • Membership in the Professional Compounding Centers of America (PCCA) • Ability to test for sterility and endotoxins • Compliance with United States Pharmacopeia (USP) guidelines • Emergency plan in place for continued services during disasters • Dedicated 24-hour emergency contact

Attached files

Contact

ALEXSANDRA JACKSON(Buyer)

[email protected]

(225) 342-8014

Key dates

Opened
2/9/2026
Closes
3/4/2026
Duration
12 months

Last updated

Details

Type
Request for Proposal
Industry
Healthcare and Medical Services
NAICS
325412
Solicitation №
3000025811

Budget estimate

$100,000 – $500,000

The budget for this contract is difficult to estimate without more information on the quantity of Hydroxocobalamin Injections required. However, considering the strict guidelines and requirements for sterility and testing, it is likely that the contract will be awarded to a vendor with significant experience and expertise in pharmaceutical preparation. The budget could range from $100,000 to $500,000 per year, depending on the volume of deliveries and the complexity of the services required. Factors that may influence the likely payment range include the number of delivery locations, the frequency of orders, and the cost of testing and quality control.

AI estimate from the solicitation

Similar opportunities

Matched by Bid Banana AI™

Bid Banana · 1.6M+ bids and awards 🍌

You found this one too late. Don't find the next one too late.

Bid Banana searches open government bids across all 50 states, updated daily. Save a search once and we email you your new matches, daily or weekly, while there is still time to win them.

1.6M+
bids & awards
All 50
states
4,000+
agencies
Start your 7-day free trial

Plans from $49.99/month. Cancel anytime, no setup fees.

Built by The Bid Lab, answering RFPs since 2017.

U.S. National Institutes of Health·United States of America

Top match · 65%

NHLBI TOPMed: Omics Phenotypes of Heart, Lung, and Blood Disorders (X01 - Clinical Trial Not Allowed)

Closes 5/8/2028Opened 7/8/2025

U.S. National Institutes of Health·United States of America

63% match

ancient DNA for Modern Genomics (aDMG) Research Projects (U01 Clinical Trials Not Allowed)

Closes 1/31/2028Opened 6/2/2026

U.S. National Institutes of Health·United States of America

63% match

The NIDDK Inflammatory Bowel Disease Genetics Consortium (IBDGC) Genomic Research Centers

Closes 10/31/2026Opened 9/18/2025

U.S. National Institutes of Health·United States of America

63% match

The NIDDK Inflammatory Bowel Disease Genetics Consortium (IBDGC) Data Coordinating Center

Closes 10/31/2026Opened 9/18/2025

U.S. National Institutes of Health·United States of America

63% match

Discovery of the Genetic Basis of Childhood Cancers and of Congenital Anomalies: Gabriella Miller Kids First Pediatric Research Program (X01 Clinical Trial Not Allowed)

Closes 1/11/2027Opened 1/20/2026

U.S. National Institutes of Health·United States of America

62% match

Screening and Functional Validation of Genomic Variants Associated with Human Congenital Anomalies (R01 Clinical Trial Not Allowed)

Closes 1/7/2028Opened 10/30/2024

U.S. National Institutes of Health·United States of America

62% match

INCLUDE Project: Omics Phenotypes Related to Down Syndrome (X01 Clinical Trial Not Allowed)

Closes 6/14/2027Opened 7/28/2026

U.S. National Institutes of Health·United States of America

62% match

Translational Efforts to Advance Gene-based Therapies for Ultra-Rare Neurological and Neuromuscular Disorders (U01 - Clinical Trial Optional)

Closes 10/8/2027Opened 12/18/2024

U.S. National Institutes of Health·United States of America

62% match

Resource-Related Research Projects for Development of Models and Related Materials for Studying Human Health and Diseases (R24 Clinical Trials Not Allowed)

Closes 9/28/2028Opened 6/9/2025

U.S. National Institutes of Health·United States of America

62% match

Somatic Mosaicism across Human Tissues (SMaHT) Program: Genome Characterization Centers (UM1 Clinical Trial Not Allowed)

Closes 6/30/2027Opened 9/14/2026

U.S. National Institutes of Health·United States of America

61% match

Systematic Characterization of Genomic Variation to Assess Effects of Individual Variants on Genome Function and Phenotype (UM1 Clinical Trials Not Allowed)

Closes 12/14/2026Opened 5/12/2025

U.S. National Institutes of Health·United States of America

61% match

Somatic Mosaicism across Human Tissues (SMaHT) Program: National Somatic Mosaicism Commons Data Analysis & Organizational Center (UM1 Clinical Trial Not Allowed)

Closes 6/30/2027Opened 9/14/2026

U.S. Food and Drug Administration·United States of America

61% match

Studies Addressing Rare Neurodegenerative Diseases including ALS

Rolling / TBD closeOpened 8/14/2024

U.S. National Institutes of Health·United States of America

60% match

Genomic Variant Interactions With Other Variants Or The Environment (UM1 Clinical Trials Not Allowed)

Closes 12/14/2026Opened 6/6/2025

U.S. Department Of Health And Human Services·Maryland

60% match

The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Seeks Industry Partners for Clinical Research Collaborations on Therapeutics, Diagnostics or Devices for Childhood Cholestatic Liver Diseases

Closes 5/31/2029Opened 9/30/2024

U.S. National Institutes of Health·United States of America

60% match

Research on the Ethical, Legal and Social Implications (ELSI) of Genomics

Closes 2/15/2027Opened 6/3/2026

U.S. National Institutes of Health·United States of America

60% match

Precision and Systems Biology to Uncover the Link Between Chronic and Infectious Diseases

Closes 1/21/2027Opened 6/24/2026

U.S. National Institutes of Health·United States of America

60% match

Learning Disabilities Research Centers

Closes 9/30/2027Opened 10/20/2026

U.S. National Institutes of Health·United States of America

60% match

Somatic Mosaicism across Human Tissues (SMaHT) Program: Experimental and Computational Technology Development (RM1 Clinical Trial Not Allowed)

Closes 6/30/2027Opened 9/14/2026

U.S. National Institutes of Health·United States of America

60% match

Accelerating Discovery through Partnered Research with All of Us to Analyze Participant Biospecimens (X01 Clinical Trial Not Allowed)

Closes 3/1/2027Opened 1/8/2026

U.S. Food and Drug Administration·United States of America

60% match

Efficient and Innovative Natural History Studies Addressing Unmet Needs in Rare Diseases (R01 Clinical Trials Optional)

Rolling / TBD closeOpened 7/11/2025

U.S. National Institutes of Health·United States of America

60% match

Computational Modeling and Analysis of the Impact of Genomic Variation on Function (UM1, Clinical Trial Not Allowed)

Closes 12/14/2026Opened 6/6/2025

U.S. National Institutes of Health·United States of America

60% match

Global Brain and Nervous System Disorders Research Across the Lifespan - Exploratory Grants

Closes 11/14/2026Opened 9/26/2025

Louisiana Office of State Procurement·Louisiana

60% match

Referral Lab Testing for CLSH-LDH

Closes 11/5/2026Opened 10/15/2026

U.S. Department Of Health And Human Services·Maryland

60% match

Clinical Research Support and Collaboration for NHGRI Protocols

Closes 11/13/2026Opened 10/26/2026